Applications of CAS No.: 37025-55-1 Carbetocin Acetate
Carbetocin Acetate, with the Chemical Abstracts Service (CAS) number 37025-55-1, is a synthetic analog of oxytocin, a hormone known for its significant role in childbirth and lactation. SACH will share the various applications of Carbetocin Acetate in the medical and pharmaceutical fields, highlighting its benefits, mechanisms of action, and potential future developments.
Chemical Structure and Synthesis
Chemical Composition
Carbetocin Acetate is a peptide hormone with a molecular structure that closely resembles oxytocin. It consists of a cyclic peptide ring and a C-terminal tail, which is modified to enhance its stability and pharmacokinetic properties.
Synthesis Process
The synthesis of Carbetocin Acetate involves a series of chemical reactions, including cyclization, acetylation, and purification steps. The process is highly controlled to ensure the purity and potency of the final product.
Mechanism of Action
Receptor Binding
Carbetocin Acetate exerts its effects by binding to oxytocin receptors, which are G-protein coupled receptors (GPCRs) found in various tissues, including the uterus.
Uterotonic Activity
The primary mechanism of action of Carbetocin Acetate is its ability to stimulate uterine contractions. This is achieved by activating oxytocin receptors, leading to an increase in intracellular calcium levels and subsequent muscle contraction.
Lactation Promotion
In addition to its uterotonic effects, Carbetocin Acetate also promotes lactation by stimulating the release of prolactin, a hormone that regulates milk production.
Clinical Applications
Prevention of Postpartum Hemorrhage
One of the most significant applications of Carbetocin Acetate is in the prevention of postpartum hemorrhage (PPH), a leading cause of maternal mortality worldwide. Administered immediately after childbirth, it helps to reduce blood loss by promoting strong, coordinated uterine contractions.
Induction of Labor
Carbetocin Acetate can also be used to induce labor in cases where natural labor is not progressing adequately. Its uterotonic effects help to initiate and maintain contractions, facilitating a smoother delivery process.
Treatment of Retained Placenta
In cases where the placenta does not deliver within 30 minutes after the birth of the baby, Carbetocin Acetate can be used to facilitate its expulsion, reducing the risk of complications such as infection and further bleeding.
Lactation Support
For mothers struggling with lactation, Carbetocin Acetate can be used to enhance milk production, ensuring adequate nutrition for the newborn.
Pharmacokinetics and Metabolism
Absorption
Carbetocin Acetate is administered via intravenous injection, ensuring rapid absorption into the bloodstream.
Distribution
Once in the bloodstream, Carbetocin Acetate is distributed throughout the body, with a particular affinity for tissues containing oxytocin receptors.
Metabolism and Elimination
The metabolism of Carbetocin Acetate primarily occurs in the liver, with the metabolites being excreted through the kidneys.
Safety and Tolerability
Side Effects
Like any drug, Carbetocin Acetate can cause side effects, which are generally mild and transient. Common side effects include nausea, vomiting, and mild hypotension.
Contraindications
Carbetocin Acetate is contraindicated in women with hypersensitivity to the drug or any of its components, as well as in cases of uterine rupture or atony unresponsive to conventional management.
Regulatory Status and Guidelines
Approval and Licensing
Carbetocin Acetate has been approved for use in various countries, with stringent regulatory processes ensuring its safety and efficacy.
Clinical Guidelines
Guidelines for the use of Carbetocin Acetate are provided by professional medical associations and are regularly updated to reflect the latest research and clinical practice.
Economic Impact and Market Analysis
Cost-Effectiveness
Carbetocin Acetate has been shown to be a cost-effective intervention for the prevention of PPH, particularly in low-resource settings.
Market Trends
The market for Carbetocin Acetate is growing, driven by an increasing awareness of PPH and the need for effective interventions to reduce maternal mortality.
Future Developments and Research
Novel Applications
Research is ongoing to explore additional applications of Carbetocin Acetate, such as its potential role in the treatment of certain cardiovascular conditions.
Drug Delivery Systems
Development of novel drug delivery systems, such as slow-release formulations, could enhance the therapeutic benefits of Carbetocin Acetate and improve patient compliance.
Combination Therapies
Investigations into the synergistic effects of Carbetocin Acetate with other drugs may lead to more effective treatment protocols for various conditions.
Conclusion
Carbetocin Acetate, with its CAS number 37025-55-1, has emerged as a valuable asset in obstetrics and gynecology, particularly in the management of postpartum hemorrhage and lactation support. Its proven efficacy, safety profile, and potential for future developments make it a promising compound in the field of reproductive health. As research continues, the applications and benefits of Carbetocin Acetate are expected to expand, further enhancing its role in improving maternal and infant health.
https://www.hzsqchem.com/Applications-of-CAS-No-37025-55-1-Carbetocin-Acetate.html
SACH
sales@hzsqchem.com
About Author
